parvovirus B19

From Aaushi
Jump to navigation Jump to search

Introduction

parvovirus B19, human

Pathology

Clinical manifestations

Laboratory

Complications

Differential diagnosis

Management

More general terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 455
  2. Medical Knowledge Self Assessment Program (MKSAP) 11,16,17,18. American College of Physicians, Philadelphia 1998,2012,2015,2018,
  3. 3.0 3.1 ARUP Consult: Parvovirus B19 The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/parvovirus-b19
  4. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007 Feb 1;75(3):373-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17304869
  5. Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004 Feb 5;350(6):586-97. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14762186
  6. 6.0 6.1 NEJM Knowledge+ May 12, 2015
  7. 7.0 7.1 Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  8. 8.0 8.1 Page C, Francois C, Goeb V, Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J Clin Virol. 2015 Nov;72:69-74. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26433772 Review.
  9. 9.0 9.1 Soderlund-Venermo M Emerging Human Parvoviruses: The Rocky Road to Fame. Annu Rev Virol. 2019 Sep 29;6(1):71-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31283445
  10. 10.0 10.1 10.2 10.3 NEJM Knowledge+